01.27.26 -- The Great Cell Therapy Reset: Solving The Industrial Math Of Living Drugs

Discover how innovative in vitro assays for CAR-T cells can enhance therapeutic outcomes by providing detailed insights into their properties and behaviors throughout pre-clinical and clinical development.

A holistic approach to CCI shifts focus from end-product testing to built-in quality across the lifecycle. Learn how science- and risk-based strategies can strengthen sterility assurance.

Cell therapies are revolutionizing cancer care, but their complex manufacturing and high costs bar access for many patients. Automation is emerging as an efficacious solution to reach patients in need.

Lipid nanoparticles (LNPs) offer a robust solution for nucleic acids. The NanoScaler system optimizes this technology, enabling scalable and reproducible LNP formulations for diverse applications.

Conventional electroporation methods struggle with damaging heat buildup. Survey how innovative flow technology leverages physics to protect cells and enable large-scale therapeutic production.

The demand for complex biologics is driving the need for intensified cell culture technologies. Perfusion using ATF has emerged as a leading solution to increase cell density and productivity.

Space constraints and sterile integrity drive the shift toward modular, robotic manufacturing. Uncover how adopting compact, automated systems reduces energy overhead and contamination risks.

From harsh chemicals to gentle enzymes: Explore the groundbreaking shift in nucleotide synthesis, making drug manufacturing cleaner, greener, and more efficient.